Isoeffect calculations with the linear quadratic and its extensions: An examination of model-dependent estimates at doses relevant to hypofractionation

Journal of Medical Physics

Volumn 36, Issue 2, 2011, Pages 100-106

  McKenna, Frederick ^a   Ahmad, Salahuddin ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Dose fractionation; hypofractionation; linear quadratic

Indexed keywords

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE CALCULATION; ISOEFFECT; LINEAR QUADRATIC; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; PROSTATE; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

EID: 79955722555     PISSN: 09716203     EISSN: 19983913     Source Type: Journal    
DOI: 10.4103/0971-6203.79689     Document Type: Article

References (26)

1. Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Amer J Clin Oncol 2007;30:637-44. (Pubitemid 350307190)
2. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2007;2:S101-12. (Pubitemid 47183603)
3. Friedland JL, Freeman DE, Masterson-McGary ME, Spellberg DM. Stereotactic body radiotherapy: An emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 2009;8:387-92.
4. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94. (Pubitemid 19194494)
5. Brenner D, Herbert D. The use of the linear-quadratic model in clinical radiation oncology can be defended on the basis of empirical evidence and theoretical argument. Med Phys 1997;24:1245-7.
6. Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Seminar Radiat Oncol 2008;18:234-9.
7. Kirkpatrick JP, Brenner DJ. The linear-quadratic model is inappropriate to model high dose per fraction effect in radiosurgery. Med Phys 2009;36:3381-4.
8. Park C, Papiez L, Zhang S, Story M, Timmerman R. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Rad Oncol Biol Phys 2008;70:847-52. (Pubitemid 351199730)
9. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985;58:515-28. (Pubitemid 15018411)
10. Sachs RK, Hahnfeld P, Brenner DJ. The link between low-LET dose response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 1997;72:351-74. (Pubitemid 27444512)
11. Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004;49:4825-35. (Pubitemid 39433509)
12. Curtis SB. Lethal and potentially lethal lesions induced by radiation: A unified repair model. Radiat Res 1986;106:252-70. (Pubitemid 16073231)
13. Liu L, Bassano D, Prasad C, Hahn S, Chung C. The linear-quadratic model and fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:827-32. (Pubitemid 37194311)
14. Haynes RH. The interpretation of microbial inactivation and recovery phenomena. Radiat Res 1966;6:S1-29.
15. Bartkowiak D, Hogner S, Nothdurft W, Rottinger E. Cell cycle and growth response of CHO cells to x-irradiation: Threshold-free repair at low doses. Int J Radiat Oncol Biol Phys 2001;50:221-7.
16. Carmichael J, Degraff W, Gamson J, Russo D, Gazdar A, Levitt M, et al. Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 1989;25:327-34.
17. Deweese T, Shipman J, Dillehay L, Nelson W. Sensitivity of human prostate carcinoma cell lines to low dose rate radiation exposure. J Urol 1998;159:591-8. (Pubitemid 28049287)
18. Garcia LM, Leblanc J, Wilkins DE, Raaphorst G. Fitting the linearquadratic model to detailed data sets for different dose ranges. Phys Med Biol 2006;51:2813-23. (Pubitemid 43832938)
19. McKenna FW, Ahmad S. Fitting techniques of cell survival curves in high dose region for use in stereotactic body radiation therapy. Phys Med Biol 2009;54:1593-608.
20. Nyman J, Johansson K, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cnacer- Mature results for medically inoperable patients. Lung Cancer 2006;51:97-103. (Pubitemid 43088629)
21. Brenner DJ. Toward optimal external beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:315-6.
22. Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica 2005;44:265-76. (Pubitemid 40904130)
23. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43: 1095-101. (Pubitemid 29144800)
24. Fowler JF, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 2001;50:1021-31. (Pubitemid 32594841)
25. Wang JZ, Guerrero M, Li XA. How low is the α/β ratio for prostate cancer. Int J Radiat Oncol Biol Phys 2003;55:194-203. (Pubitemid 36020360)
26. Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M. Comparison of in vitro and in vivo a/b ratios for prostate cancer. Phys Med Biol 2004;49:4477-91. (Pubitemid 39378241)